Volume 21, Issue 3, Pages (February 2006)

Slides:



Advertisements
Similar presentations
Molecular Therapy - Nucleic Acids
Advertisements

Volume 55, Issue 1, Pages (July 2014)
Volume 28, Issue 3, Pages (November 2007)
Volume 28, Issue 4, Pages (November 2007)
Demián Cazalla, Mingyi Xie, Joan A. Steitz  Molecular Cell 
Volume 76, Issue 7, Pages (October 2009)
Volume 10, Issue 1, Pages (July 2002)
Marco Baralle, Tibor Pastor, Erica Bussani, Franco Pagani 
Reccurrent F8 Intronic Deletion Found in Mild Hemophilia A Causes Alu Exonization  Yohann Jourdy, Alexandre Janin, Mathilde Fretigny, Anne Lienhart, Claude.
Crosstalk between mRNA 3′ End Processing and Transcription Initiation
Volume 5, Issue 2, Pages (February 2000)
Xu Shi-wen, Christopher P. Denton, Alan M. Holmes, Carol M
Volume 16, Issue 5, Pages (December 2004)
Volume 27, Issue 6, Pages (September 2007)
Volume 46, Issue 4, Pages (May 2012)
Volume 24, Issue 6, Pages (December 2006)
Human Senataxin Resolves RNA/DNA Hybrids Formed at Transcriptional Pause Sites to Promote Xrn2-Dependent Termination  Konstantina Skourti-Stathaki, Nicholas J.
John T. Arigo, Kristina L. Carroll, Jessica M. Ames, Jeffry L. Corden 
Volume 22, Issue 4, Pages (May 2006)
Exon Circularization Requires Canonical Splice Signals
Volume 154, Issue 6, Pages (September 2013)
Volume 13, Issue 1, Pages (January 2004)
Volume 37, Issue 6, Pages (March 2010)
Volume 3, Issue 4, Pages (April 2013)
Identification and differential expression of human collagenase-3 mRNA species derived from internal deletion, alternative splicing, and different polyadenylation.
Volume 18, Issue 2, Pages (April 2005)
Volume 5, Issue 6, Pages (December 2013)
Volume 29, Issue 1, Pages (January 2008)
DNA Methylation Mediated by a MicroRNA Pathway
John T. Arigo, Daniel E. Eyler, Kristina L. Carroll, Jeffry L. Corden 
Andrew J Henderson, Ruth I Connor, Kathryn L Calame  Immunity 
Transcriptional Termination Enhances Protein Expression in Human Cells
Volume 25, Issue 3, Pages (February 2007)
Volume 29, Issue 2, Pages (February 2008)
Jung-Ok Han, Sharri B Steen, David B Roth  Molecular Cell 
Posttranscriptional Crossregulation between Drosha and DGCR8
Pseudoexon Activation as a Novel Mechanism for Disease Resulting in Atypical Growth- Hormone Insensitivity  Louise A. Metherell, Scott A. Akker, Patricia.
Volume 45, Issue 5, Pages (March 2012)
Xinyang Zhao, P.Shannon Pendergrast, Nouria Hernandez  Molecular Cell 
Volume 37, Issue 1, Pages (January 2010)
Volume 25, Issue 3, Pages (February 2007)
Yingqun Huang, Joan A. Steitz  Molecular Cell 
Volume 25, Issue 4, Pages (February 2007)
Beth Elliott, Christine Richardson, Maria Jasin  Molecular Cell 
Volume 20, Issue 5, Pages (December 2005)
Nuclear Retention Prevents Premature Cytoplasmic Appearance of mRNA
The Mammalian RNA Polymerase II C-Terminal Domain Interacts with RNA to Suppress Transcription-Coupled 3′ End Formation  Syuzo Kaneko, James L. Manley 
ADAR Regulates RNA Editing, Transcript Stability, and Gene Expression
Volume 8, Issue 4, Pages (October 2001)
The Proteasome Restricts Permissive Transcription at Tissue-Specific Gene Loci in Embryonic Stem Cells  Henrietta Szutorisz, Andrew Georgiou, László Tora,
Regulation of the Expression of Peptidylarginine Deiminase Type II Gene (PADI2) in Human Keratinocytes Involves Sp1 and Sp3 Transcription Factors  Sijun.
Reccurrent F8 Intronic Deletion Found in Mild Hemophilia A Causes Alu Exonization  Yohann Jourdy, Alexandre Janin, Mathilde Fretigny, Anne Lienhart, Claude.
Distinct Pathways for snoRNA and mRNA Termination
Volume 25, Issue 2, Pages (February 2017)
Volume 30, Issue 6, Pages (June 2008)
Assessing the Functional Characteristics of Synonymous and Nonsynonymous Mutation Candidates by Use of Large DNA Constructs  A.M. Eeds, D. Mortlock, R.
CRISPR/Cas9-Mediated Deletion of CTG Expansions Recovers Normal Phenotype in Myogenic Cells Derived from Myotonic Dystrophy 1 Patients  Claudia Provenzano,
Patricia J. Hilleren, Roy Parker  Molecular Cell 
Sang-Hyun Song, Chunhui Hou, Ann Dean  Molecular Cell 
Michael J Dye, Nick J Proudfoot  Molecular Cell 
Promoting in Tandem: The Promoter for Telomere Transposon HeT-A and Implications for the Evolution of Retroviral LTRs  O.N Danilevskaya, I.R Arkhipova,
Steven West, Nicholas J. Proudfoot, Michael J. Dye  Molecular Cell 
Jiamiao Lu, Feijie Zhang, Mark A Kay  Molecular Therapy 
Exon Tethering in Transcription by RNA Polymerase II
Molecular Therapy - Nucleic Acids
Volume 55, Issue 1, Pages (July 2014)
Exon Skipping in IVD RNA Processing in Isovaleric Acidemia Caused by Point Mutations in the Coding Region of the IVD Gene  Jerry Vockley, Peter K. Rogan,
The Proteasome Restricts Permissive Transcription at Tissue-Specific Gene Loci in Embryonic Stem Cells  Henrietta Szutorisz, Andrew Georgiou, László Tora,
Volume 18, Issue 4, Pages (May 2005)
Jörg Hartkamp, Brian Carpenter, Stefan G.E. Roberts  Molecular Cell 
Presentation transcript:

Volume 21, Issue 3, Pages 437-443 (February 2006) Adenylation and Exosome-Mediated Degradation of Cotranscriptionally Cleaved Pre- Messenger RNA in Human Cells  Steven West, Natalia Gromak, Christopher J. Norbury, Nicholas J. Proudfoot  Molecular Cell  Volume 21, Issue 3, Pages 437-443 (February 2006) DOI: 10.1016/j.molcel.2005.12.008 Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 1 hscRACE Analysis of β-Globin Transcripts (A) hscRACE procedure: (1) CoTC sequence is represented by a hatched box, exon 3 is indicated by a white box, and unknown sites of CoTC are shown as lightening bolts. Enrichment of β-globin transcripts through magnetic selection of hybridized biotinylated RNA (black line and circle) upstream of the poly(A) site [p(A)] precedes release of transcripts through hybridization of DNA oligo (dotted line) followed by RNaseH cleavage. (2) Released RNA with unknown 3′ ends is ligated to form circles (3), which are then reverse transcribed with a cDNA primer (arrow) directed to amplify across the ligated junction. (4) Linear cDNA is amplified by PCR using primers (gray and black arrows) that will only amplify cDNA obtained from ligated RNA. Products were analyzed on a gel and (5) sequenced. (B) Polyacrylamide gel electophoretic analysis of hscRACE products from βΔ5–7-transfected cells. Size markers are indicated on the right-hand side. Three major products are labeled (i)–(iii). The selection of bands analyzed by cloning and sequencing is denoted by bracket. (C) CoTC RNA sequence: positions of CoTC-derived ends are indicated by arrows, where each arrow represents an individual clone. Nontemplated residues are indicated above the arrow that represents their position. CoTC hotspots are underlined. A tails observed upon PMscl100 depletion are denoted by white arrows, and their sequence is underlined in bold type. Molecular Cell 2006 21, 437-443DOI: (10.1016/j.molcel.2005.12.008) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 2 hscRACE Analysis of Human β-Globin CoTC (A) Western blot showing RNAi knockdown of PMscl100. The actin loading control is shown in the bottom panel, and the PMscl100 blot is shown in the top panel. (B) S1 nuclease analysis of globin mRNA with (+) or without (−) siRNA treatment. β-globin mRNA and VA RNA signals are indicated. (C) hscRACE analysis of RNA from βΔ5–7 transfected cells with (+) or without (−) siRNA treatment. PCR cycle number is indicated above the gel by the appropriate number. Bands (i)–(iii) are also indicated. (D) hscRACE analysis of βΔ5–7pAmut as in (C). PCR cycle number is indicated above the gel. Bands (i)–(iii) are again indicated. Molecular Cell 2006 21, 437-443DOI: (10.1016/j.molcel.2005.12.008) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 3 hscRACE Analysis of PMscl75-Depleted Cells and RNA Cleaved at the Poly(A) Site (A) RT-PCR analysis of PMscl75 knockdown. PCR products deriving from actin and PMscl75 mRNAs are shown. Presence (+) or absence (−) of PMscl75-specific siRNA is also indicated. (B) hscRACE analysis of RNA from wt (−) and PMscl75 siRNA-treated (+) cells. Bands (i)–(iii) are shown, and PCR cycle number is also indicated. (C) hscRACE analysis of RNA, from wt cells and cells treated with either PMscl75 or PMscl100 siRNAs (appropriately indicated by a +), which has been cleaved at the poly(A) site. The number of PCR cycles used is indicated. Molecular Cell 2006 21, 437-443DOI: (10.1016/j.molcel.2005.12.008) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 4 MSA Hybrid Selection NRO and hscRACE (A) Diagram of βAlb: β-globin exons (black) and intervening introns are shown downstream of the HIV promoter (horizontal arrow). The β-globin poly(A) site is indicated, as is the MSA 3′ flanking region insert (gray box). Single-stranded M13 probes used in NRO analysis are indicated in bold type and are underlined. (B) Hybrid selection nuclear run-on analysis of βAlb: selected (S) and unselected (US) panels are shown, and corrected hybridization signals are quantitated graphically. (C) hscRACE analysis of βAlb. Diagram shows relative positions of the biotinylated probe (black line and circle), the oligo used for RNaseH release (dotted line), and oligos used for reverse transcription (gray arrowhead) and PCR (gray and black arrowheads). Polyacrylamide gel separation of the multiple bands produced is shown on the right. The selection of bands that were cloned is indicated by a bracket. (D) Albumin CoTC sequence with positions of cloned ends indicated by black arrows. Adenylated species from wt cells (bold) and PMscl100-depleted cells (underlined) are also indicated. Molecular Cell 2006 21, 437-443DOI: (10.1016/j.molcel.2005.12.008) Copyright © 2006 Elsevier Inc. Terms and Conditions